In vivo morphological changes in animal models of amyotrophic lateral sclerosis and Alzheimer's-like disease: MRI approach

Anatomical Record

Volumn 292, Issue 12, 2009, Pages 1882-1892

  Andjus, Pavle R ^a   Bataveljić, Danijela ^a   Vanhoutte, Greetje ^b   Mitrecic, Dinko ^c   Pizzolante, Fabrizio ^d   Djogo, Nevena ^a   Nicaise, Charles ^c   Kengne, Fabrice Gankam ^c   Gangitano, Carlo ^d   Michetti, Fabrizio ^d   Van Der Linden, Annemie ^b   Pochet, Roland ^c   Bačić, Goran ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d CATHOLIC UNIVERSITY   (Italy)

Author keywords

ALS; Astrocytes; Blood brain barrier; CD4; Microglia; MRI; T cells; Trimethyltin

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GADOLINIUM PENTETATE; GLIAL FIBRILLARY ACIDIC PROTEIN; TRIMETHYLTIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ASTROCYTOSIS; BLOOD BRAIN BARRIER; BRAIN ATROPHY; BRAIN STEM; BRAIN VENTRICLE DILATATION; CD4+ T LYMPHOCYTE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; INFLAMMATORY INFILTRATE; LATERAL BRAIN VENTRICLE; NERVE DEGENERATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; ENCEPHALITIS; GLIOSIS; HUMANS; MAGNETIC RESONANCE IMAGING; NERVE DEGENERATION; RATS;

ANIMALIA; RATTUS;

EID: 73849083781     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.20995     Document Type: Conference Paper

References (70)

1. Alexianu ME, Kozovska M, Appel SH. 2001. Immune reactivity in a mouse model of familial ALS correlates with disease progression. Neurology 57:1282-1289.
2. Anderson SA, Shukaliak-Quandt J, Jordan EK, Arbab AS, Martin R, McFarland H, Frank JA. 2004. Magnetic resonance imaging of labeled T-cells in a mouse model of multiple sclerosis. Ann Neurol 55:654-659.
3. Angenstein F, Niessen HG, Goldschmidt J, Vielhaber S, Ludolph AC, Scheich H. 2004. Age-dependent changes in MRI of motor brain stem nuclei in a mouse model of ALS. Neuroreport 15:2271-2274.
4. Appel SH, Simpson EP. 2001. Activated microglia: the silent executioner in neurodegenerative disease? Curr Neurol Neurosci Rep 1:303-305.
5. Ashburner J, Fristone KJ. 2000. Voxel based morphometry-the methods. Neuroimage 11:805-821.
6. Balaban CD, O'Callaghan JP, Billingsley ML. 1988. Trimethyltininduced neuronal damage in the rat brain: comparative studies using silver degeneration stains, immunocytochemistry and immunoassay for neuronotypic and gliotypic proteins. Neuroscience 26:337-361.
7. Basak M, Erturk M, Oflazoglu B, Ozel A, Yildiz GB, Forta H. 2002. Magnetic resonance imaging in amyotrophic lateral sclerosis. Acta Neurol Scand 105:395-399.
8. Beers DR, Henkel JS, Zhao W, Wang J, Appel SH. 2008. Proc Natl Acad Sci USA 105:15558-155563.
9. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. 2006. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312:1389-1392.
10. Braakman N, Matysik J, van Duinen SG, Verbeek F, Schliebs R, de Groot HJ, Alia A. 2006. Longitudinal assessment of Alzheimer's beta-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging. J Magn Reson Imaging 24:530-536.
11. Brickman AM, Honig LS, Scarmeas N, Tatarina O, Sanders L, Albert MS, Brandt J, Blacker D, Stern Y. 2008. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. Arch Neurol 65:1202-1208.
12. Brown AW, Aldridge WN, Street BW, Verschoyle RD. 1979. The behavioural and neuropathological sequelae of intoxication by trimethyltin compounds in the rat. Am J Pathol 97:59-82.
13. Bruijn LI, Miller TM, Cleveland DW. 2004. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 27:723-749.
14. Bucher S, Braunstein KE, Niessen HG, Kaulisch T, Neumaier M, Boeckers TM, Stiller D, Ludolph AC. 2007. Vacuolization correlates with spin-spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS. Eur J Neurosci 26:1895-1901.
15. Bulte JW, Kraitchman DL. 2004. Iron oxide MR contrast agents for molecular and cellular imaging. NMR Biomed 17:484-499. Chua TC, Wen W, Slavin MJ, Sachdev PS. 2008. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurol 21:83-92.
16. Corvino V, Geloso MC, Cavallo V, Guadagni E, Passalacqua R, Florenzano F, Giannetti S, Molibnari M, Michetti F. 2005. Enhanced neurogenesis during trimethyltin-induced neurodegeneration in the hippocampus of the adult rat. Brain Res Bull 65:471-477.
17. Dedeoglu A, Choi JK, Cormier K, Kowall NW, Jenkins BG. 2004. Magnetic resonance spectroscopic analysis of Alzheimer's disease mouse brain that express mutant human APP shows altered neurochemical profile. Brain Res 1012:60-65.
18. Dyer RS, Deshilds TL, Wonderlich WF. 1982. Trimethyltininduced changes in gross morphology of the hippocampus. Neurobehav Toxicol Teratol 4:141-147.
19. Ellis CM, Simmons A, Jones DK, Bland J, Dawson JM, Horsfield MA, Williams SC, Leigh PN. 1999. Diffusion tensor MRI assesses corticospinal changes. Neurology 53:1051-1058.
20. Floris S, Blezer EL, Schreibelt G, Dopp E, van der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE. 2004. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127:616-627.
21. Fortemp E, Amand G, Lauwerys R, Laterre EC. 1978. Trimethyltin poisoning. Report of two cases. Int Arch Occup Environ Health 41:1-6.
22. Frank B, Haas J, Heinze HJ, Stark E, Munte TF. 1997. Relation of neurophysiological and magnetic resonance findings in amyotrophyc lateral scelerosis: evidence of subgroups. Clin Neurol Neurosurg 99:79-86.
23. Garbuzova-Davis S, Haller E, Saporta S, Kolomey I, Nicosia SV, Sanberg PR. 2007a. Ultrastructure of blood-brain barrier and blood-spinal cord barrier in SOD1 mice modeling ALS. Brain Res 1157:126-137.
24. Garbuzova-Davis S, Saporta S, Haller E, Kolomey I, Bennett SP, Potter H, Sanberg PR. 2007b. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS. PLoS ONE 2:e1205.
25. Geloso MC, Corvino V, Cavallo V, Toesca A, Guadagni E, Passalacqua R, Michetti F. 2004. Expression of astrocytic nestin in the rat hippocampus during trimethyltin-induced neurodegeneration. Neurosci Lett 357:103-106.
26. Geloso MC, Vinesi P, Michetti F. 1996. Parvalbumin-immunoreactive neurons are not affected by trimethyltin-induced neurodegeneration in the rat hippocampus. Exp Neurol 139:269-277.
27. Geloso MC, Vinesi P, Michetti F. 1997. Calretinin-containing neurons in trimethyltin-induced neurodegeneration in the rat hippocampus: an immunocytochemical study. Exp Neurol 146:67-73.
28. Gurney ME. 1997. Transgenic animal models of familial amyotrophic lateral sclerosis. J Neurol 244 (Suppl 2):S15-S20.
29. Harry GJ, McPherson C, Wine RN, Atkinson K, d'Hellencourt CL. 2004. Trimethyltin-induced neurogenesis in the murine hippocampus. Neurotox Res 5:623-627.
30. Hecht MJ, Fellner F, Fellner C, Hilz MJ, Neundorfer B, Heuss D. 2002. Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images. J Neurol Sci 199:59-65.
31. Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH. 2004. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol 55:221-235.
32. Howland DS, Liu J, She Y, Goad B, Maragakis NJ, Kim B, Erickson J, Kulik J, DeVito L, Psaltis G, DeGennaro LJ, Cleveland DW, Rothstein JD. 2002. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci USA 99:1604-1609.
33. Jefferies WA, Green JR, Williams AF. 1985. Authentic T helper CD4 (W3/25) antigen on rat peritoneal macrophages. J Exp Med 162: 117-127.
34. Kalra S, Cashman NR, Caramanos Z, Genge A, Arnold DL. 2003. Gabapentin therapy for amyotrophic lateral sclerosis: lack of improvement in neuronal integrity shown by MR spectroscopy. Am J Neuroradiol 24:476-480.
35. Kalra S, Tai P, Genge A, Arnold DL. 2006. Rapid improvement in cortical neuronal integrity in amyotrophic lateral sclerosis detected by proton magnetic resonance spectroscopy. J Neurol 253:1060-1063.
36. Kassed CA, Butler TL, Navidomskis MT, Gordon MN, Morgan D, Pennypacker KR. 2003. Mice expressing human mutant presenilin-1 exhibit decreased activation of NF-kappaB p50 in hippocampal neurons after injury. Brain Res Mol Brain Res 110:152-157.
37. Larsen M, Bjarkam CR, Stoltenberg M, Sørensen JC, Danscher G. 2003. An autometallographic technique for myelin staining in formaldehyde-fixed tissue. Histol Histopathol 18:1125-1130.
38. Lattanzi W, Bernardini C, Gangitano C, Michetti F. 2007. Hypoxialike transcriptional activation in TMT-induced degeneration: microarray expression analysis. J Neurochem 100:1688-1702.
39. Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ. 2008. ALS and FTLD: two faces of TDP-43 proteinopathy. Eur J Neurol 15:772-780.
40. Little AR, Benkovic SA, Miller DB, O'Callaghan JP. 2002. Chemically induced neuronal damage and gliosis: enhanced expression of the proinflammatory chemokine, monocyte chemoattractant protein (MCP)-1, without a corresponding increase in proinflammatory cytokines. Neuroscience 115:307-320.
41. Lowry KS, Murray SS, McLean CA, Talman P, Mathers S, Lopes EC, Cheema SS. 2001. A potential role for the p75 low-affinity neurotrophin receptor in spinal motor neuron degeneration in murine and human amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2:127-134.
42. McGeer PL, McGeer EG. 2002. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459-470.
43. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, Fogarty J, Bartha R. 2008. Alzheimer's disease neuroimaging initiative. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 131:2443-2454.
44. Nicaise C, Coupier J, Dabadie MP, De Decker R, Mangas A, Bodet D, Poncelet L, Geffard M, Pochet R. 2008. Gemals, a new drug candidate, extends lifespan and improves muscular performance in an amyotrophic lateral sclerosis rat model. Amyotroph Lateral Scler 9:85-90.
45. Nicaise C, Soyfoo MS, Authelet M, De Decker R, Bataveljic D, Delporte C, Pochet R. 2009. Aquaporin-4 overexpression in rat ALS model. Anat Rec (Hoboken) 292:207-213.
46. Niessen HG, Angenstein F, Sander K, Kunz WS, Teuchert M, Ludolph AC, Heinze HJ, Scheich H, Vielhaber S. 2006. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Exp Neurol 20:293-300.
47. Niessen HG, Debska-Vielhaber G, Sander K, Angenstein F, Ludolph AC, Hilfert L, Willker W, Leibfritz D, Heinze HJ, Kunz WS, Vielhaber S. 2007. Metabolic progression markers of neurodegeneration in the transgenic G93A-SOD1 mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25:1669-1677.
48. Patel M, Ardtel BK, Yim GK, Isom GE. 1990. Interaction of trimethyltin with hippocampal glutamate. Neurotoxicology 11:601-608.
49. Philippeau M, Manto M, Sokolow S, Laute M-A, Brion J-P, Pandolfo M, Pochet R. 2005. Recent advances in transgenic models of ALS- electrophysiological, morphological and neurochemical characterization of hSOD-1 G93A transgenic rats. Rec Res Dev Physiol 3:13-31.
50. Piacentini R, Gangitano C, Ceccariglia S, Del Fà A, Azzena GB, Michetti F, Grassi C. 2008. Dysregulation of intracellular calcium homeostasis is responsible for neuronal death in an experimental model of selective hippocampal degeneration induced by trimethyltin. J Neiurochem 105:2109-2121.
51. Pirko I, Ciric B, Johnson AJ, Gamez J, Rodriguez M, Macura S. 2003. Magnetic resonance imaging of immune cells in inflammation of central nervous system. Croat Med J 44:463-468.
52. Pirko I, Johnson A, Ciric B, Gamez J, Macura SI, Pease LR, Rodriguez M. 2004. In vivo magnetic resonance imaging of immune cells in the central nervous system with superparamagnetic antibodies. FASEB J 18:179-182.
53. Redwine JM, Kosofsky B, Jacobs RE, Games D, Reilly JF, Morrison JH, Young WG, Bloom FE. 2003. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci USA 100:1381-1386.
54. Schenk JF, Zimmerman EA. 2004. High-field magnetic resonance imaging of brain iron: birth of biomarker? NMR Biomed 17:433-445.
55. Shi N, Kawano Y, Tateishi T, Kikuchi H, Osoegawa M, Ohyagi Y, Kira J. 2007. Increased IL-13-producing T cells in ALS: positive correlations with disease severity and progression rate. J Neuroimmunol 182:232-235.
56. Stankiewicz J, Panter SS, Neema M, Arora A, Batt CE, Bakshi R. 2007. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 4:371-386.
57. Stoll G, Bendszus M. 2009. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Neuroscience 158:1151-1160.
58. Suhy J, Miller RG, Rule R, Schuff N, Licht J, Dronsky V, Gelinas D, Maudsley AA, Weiner MW. 2002. Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology 58:773-779.
59. Sun SW, Song SK, Harms MP, Lin SJ, Holtzman DM, Merchant KM, Kotyk JJ. 2005. Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Exp Neurol 191:77-85.
60. Terry RD. 2006. Alzheimer's disease and the aging brain. J Geriatr Psychiatry Neurol 19:125-128.
61. Turner MR, Hammers A, Al-Chalabi A, Shaw CE, Andersen PM, Brooks DJ, Leigh PN. 2007. Cortical involvement in four cases of primary lateral sclerosis using [(11)C]-fl umazenil PET. J Neurol 254:1033-1036.
62. Turner MR, Kiernan MC, Leigh PN, Talbot K. 2009. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol 8:94-109.
63. Van Broeck B, Vanhoutte G, Pirici D, Van Dam D, Wils H, Cuijt I, Vennekens K, Zabielski M, Michalik A, Theuns J, De Deyn PP, Van der Linden A, Van Broeckhoven C, Kumar-Singh S. 2008. Intraneuronal amyloid beta and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease. Neurobiol Aging 29:241-252.
64. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A. 2005. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimers's disease. Magn Reson Med 53: 603-613.
65. Verbalis JG, Martinez AJ. 1991. Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int 39:1274-1282.
66. Vinesi P, Geloso MC, Michetti F. 1997. S100 proteins in trimethyltin-induced neurodegeneration in the rat hippocampus. An immunochemical and immunocytochemical study. Mol Chem Neuropathol 32:129-141.
67. Zang DW, Yang Q, Wang HX, Egan G, Lopes EC, Cheema SS. 2004. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 20:1745-1751.
68. Zhang L, Ulug AM, Zimmerman RD, Lin MT, Rubin M, Beal MF. 2003. The diagnostic utility of FLAIR imaging in clinicaly veri-fied amyotrophic lateral sclerosis. J Magn Reson Imaging 17:521-527.
69. Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, Jin X, Reis J, Narvaez A, McGrath MS. 2005. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS). J Neuroimmunol 159:215-224.
70. Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, Stojanovic K, Sagare A, Boillee S, Cleveland DW, Zlokovic BV. 2008. ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nat Neurosci 11: 420-422.